BridgeMD
New treatment option for Generalized Anxiety
Official title Optimization of Late Imagery Rescripting Research Using Generative Artificial Intelligence
ClinicalTrials.gov ID: NCT07565714
What this study is testing
- What it's testing
- The aim of the study is to examine the effect of imagery rescripting (ImRs) in the context of utilizing large language models (LLMs). Intervention will involve the prior presentation of the most aversive fragment of the memory, the so-called 'hotspot.' This intervention will allow for the replication of the effect described by Dibbets and Arntz (2016), according to which the prior activation of the most emotional element of a memory enhances the effectiveness of ImRs.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35
You may be able to join if
- Age 18-35
- Score ≥ 8 on GAD-7 (Plummer et al., 2016)
- Ability to recall at least two childhood memories involving parental criticism
You likely can't join if
- History of prolonged physical or sexual abuse
- Current psychotherapy or psychopharmacology
- PTSD diagnosis (DSM-5 screening)
- Substance abuse (TAPS tool)
The study team makes the final eligibility decision.
Where it's taking place
- Poznan, Wielkopolska, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Poznan, Wielkopolska, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.